These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16457266)

  • 21. Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy.
    Machlenkin A; Paz A; Bar Haim E; Goldberger O; Finkel E; Tirosh B; Volovitz I; Vadai E; Lugassy G; Cytron S; Lemonnier F; Tzehoval E; Eisenbach L
    Cancer Res; 2005 Jul; 65(14):6435-42. PubMed ID: 16024648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTL in mice immunized with human mucin 1 are MHC-restricted.
    Apostolopoulos V; Loveland BE; Pietersz GA; McKenzie IF
    J Immunol; 1995 Dec; 155(11):5089-94. PubMed ID: 7594517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor effect induced by dendritic cell (DC)-based immunotherapy against peritoneal dissemination of the hamster pancreatic cancer.
    Takigawa Y; Akiyama Y; Maruyama K; Sugiyama K; Uchida E; Kosuge T; Ueda M; Kitajima M; Yamaguchi K
    Cancer Lett; 2004 Nov; 215(2):179-86. PubMed ID: 15488636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
    Jerome KR; Domenech N; Finn OJ
    J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New mucin core protein genes and their clinical application].
    Imai K
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):139-43. PubMed ID: 8641670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
    Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.
    Schmidt T; Ziske C; Märten A; Endres S; Tiemann K; Schmitz V; Gorschlüter M; Schneider C; Sauerbruch T; Schmidt-Wolf IG
    Cancer Res; 2003 Dec; 63(24):8962-7. PubMed ID: 14695214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased tumor surveillance after adoptive T-cell therapy.
    Matter M; Pavelic V; Pinschewer DD; Mumprecht S; Eschli B; Giroglou T; von Laer D; Ochsenbein AF
    Cancer Res; 2007 Aug; 67(15):7467-76. PubMed ID: 17671217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on vaccine development in AIDS and cancer.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1995 Apr; 1(3):18-24. PubMed ID: 11362485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
    Dupont J; Latouche JB; Ma C; Sadelain M
    Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MUC1-specific cytotoxic T lymphocytes eradicate tumors when adoptively transferred in vivo.
    Mukherjee P; Ginardi AR; Tinder TL; Sterner CJ; Gendler SJ
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):848s-855s. PubMed ID: 11300482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy.
    Pion S; Fontaine P; Baron C; Gyger M; Perreault C
    J Clin Invest; 1995 Apr; 95(4):1561-8. PubMed ID: 7706462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [MUC1, a therapeutic target in oncology].
    Limacher JM; Acres B
    Bull Cancer; 2007 Mar; 94(3):253-7. PubMed ID: 17371767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytotoxic T-lymphocytes and the recognition of tumor antigens--an approach to "preventive tumor vaccination?"].
    Peiper M; Goedegebuure PS; Eberlein TJ; Zornig C
    Zentralbl Chir; 1997; 122(3):141-8. PubMed ID: 9206906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucin-1 is expressed on dendritic cells, both in vitro and in vivo.
    Cloosen S; Thio M; Vanclée A; van Leeuwen EB; Senden-Gijsbers BL; Oving EB; Germeraad WT; Bos GM
    Int Immunol; 2004 Nov; 16(11):1561-71. PubMed ID: 15381671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered MUC1 epitope-specific CTLs: A potential target for immunotherapy of pancreatic cancer.
    Hong J; Guo G; Wu S; Lin S; Zhou Z; Chen S; Ye C; Li J; Lin W; Ye Y
    J Leukoc Biol; 2022 Dec; 112(6):1577-1590. PubMed ID: 36222123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study of the association between the progression of pancreatic ductal lesions and the expression of MUC1, MUC2, MUC5AC, and E-cadherin.
    Kigure S
    Rinsho Byori; 2006 May; 54(5):447-52. PubMed ID: 16789413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
    Oelke M; Moehrle U; Chen JL; Behringer D; Cerundolo V; Lindemann A; Mackensen A
    Clin Cancer Res; 2000 May; 6(5):1997-2005. PubMed ID: 10815925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Future prospects for specific immunotherapy].
    Sugaya M; Takenoyama M; Yasumoto K
    Nihon Rinsho; 2002 May; 60 Suppl 5():609-13. PubMed ID: 12101747
    [No Abstract]   [Full Text] [Related]  

  • 40. Three-step tumor targeting via biotin-avidin interaction as a versatile system to elicit T cell-mediated, non-MHC-restricted cytotoxic activity against neoplastic cells.
    Guidi F; Spagnoli GC; Neri G; Paganelli G; Siccardi AG; Guttinger M
    Int J Cancer; 1998 May; 76(3):443-7. PubMed ID: 9579585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.